Standard Glass Lining IPO GMP Today, Date, Price, Subscription Status 

Standard Glass Lining IPO Overview

Iifl Securities Ltd, Motilal Oswal Investment Advisors Limited are the book running  lead manager  of the Standard Glass Lining IPO, while Kfin Technologies Limited is the registrar for the issue.

Refer to Standard Glass Lining IPO RHP for detailed information.

Standard Glass Lining IPO Important dates

Standard Glass Lining IPO opens on January 6, 2025, and closes on January 8, 2025.

IPO Open Date	Monday, January 6, 2025
IPO Close Date	Wednesday, January 8, 2025
Basis of Allotment	Thursday, January 9, 2025
Initiation of Refunds	Friday, January 10, 2025
Credit of Shares to Demat	Friday, January 10, 2025
Listing Date	Monday, January 13, 2025
Cut-off time for UPI mandate confirmation	5 PM on January 8, 2025

Standard Glass Lining IPO Financial Performance

Standard Glass Lining Technology Limited’s revenue increased by 10% and profit after tax (PAT) rose by 12% between the financial year ending with March 31, 2024 and March 31, 2023.

Standard Glass Lining IPO Key Performance Indicator

The market capitalization of Standard Glass Lining IPO is Rs 2792.88 Cr.

KPI as of Sun, Mar 31, 2024.

Standard Glass Lining IPO Objectives

The Company proposes to utilize the Net Proceeds towards funding the following objects:

1. Funding of capital expenditure requirements of the Company towards the purchase of machinery and equipment;
2. Repayment or prepayment, in full or in part, of all or a portion of certain outstanding borrowings availed by the Company and investment in the wholly owned Material Subsidiary, S2 Engineering Industry Private Limited, for repayment or prepayment, in full or in part, of all or a portion of certain outstanding borrowings availed by S2 Engineering Industry Private Limited, from banks and financial institutions;
3. Investment in the wholly owned Material Subsidiary, S2 Engineering Industry Private Limited, for funding its capital expenditure requirements towards purchase of machinery and equipment;
4. Funding inorganic growth through strategic investments and/or acquisitions and
5. General corporate purposes

Standard Glass Lining IPO Lot Size

Investors can bid for a minimum of 107 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.

Application	Lots	Shares	Amount
Retail (Min)	1	107	₹14,980
Retail (Max)	13	1391	₹1,94,740
S-HNI (Min)	14	1,498	₹2,09,720
S-HNI (Max)	66	7,062	₹9,88,680
B-HNI (Min)	67	7,169	₹10,03,660

Standard Glass Lining IPO Details

IPO Date	January 6, 2025 to January 8, 2025
Listing Date	[.]
Face Value	₹10 per share
Price Band	₹133 to ₹140 per share
Lot Size	107 Shares
Total Issue Size	2,92,89,367 shares (aggregating up to ₹410.05 Cr)
Fresh Issue	1,50,00,000 shares (aggregating up to ₹ 210.00 Cr)
Offer for Sale	1,42,89,367 shares of ₹10 (aggregating up to ₹200.05 Cr)
Issue Type	Book Built Issue IPO
Listing At	BSE, NSE
Share Holding Pre Issue	18,44,91,662 shares
Share Holding Post Issue	19,94,91,662 shares

Standard Glass Lining IPO Company Overview and Services

Incorporated in September 2012, Standard Glass Lining Technology Limited is a manufacturer of engineering equipment for the pharmaceutical and chemical sectors in India. The company has the capability to manage the entire production process in-house.

The company provides turnkey solutions, including design, engineering, manufacturing, assembly, installation, and standard operating procedures for pharmaceutical and chemical manufacturers.

The company’s product product portfolio includes

• Reaction Systems;
• Storage, Separation and Drying Systems; and
• Plant, Engineering and Services

The company manufactures specialized engineering equipment using glass-lined materials, stainless steel, and nickel alloy.

The company’s customer includes Apitoria Pharma Private Limited, Aurobindo Pharma Limited, CCL Food and Beverages Private Limited, Cohance Lifesciences Limited, Cadila Pharmaceutical Limited, Deccan Fine Chemicals (India) Private Limited, Dasami Lab Private Limited, Laurus Labs Limited, Granules India Limited, Macleods Pharmaceuticals Limited, MSN Laboratories Private Limited, Natco Pharma Limited, Honour Lab Limited, Hetero Drugs Limited, Hetero Labs Limited, Hazelo Lab Private Limited, Piramal Pharma Limited, Sanvira Biosciences Private Limited, Suven Pharmaceuticals Limited, Tagros Chemicals India Private Limited, Vamsi Labs Limited and Viyash Life Sciences Private Limited.

The company has eight manufacturing units situated in Hyderabad, Telangana.

The company’s sales offices are situated in Vadodara, Gujarat, Ankleshwar, Gujarat, Mumbai, Maharashtra and Vishakhapatnam, Andhra Pradesh and sales team members are in Jhagadia, Gujarat, Chennai, Tamil Nadu, New Delhi, Bengaluru, Karnataka and Vijayawada, Andhra Pradesh with pan-India reach.

As of September 30, 2024, the company had 460 full-time employees and 731 contract labourers.

Competitive Strength

1. Specialised engineering equipment manufacturers for the pharmaceutical and chemical sectors.
2. Customized and innovative range of products throughout the entire pharmaceutical and chemical manufacturing value chain.
3. Strategically located manufacturing facilities with advanced technological capabilities.
4. Long term relationships with marquee clientele across sectors.
5. Consistent track record of profitable growth.

Standard Glass Lining IPO SWOT Analysis

Strengths:

• Specialized Expertise: Standard Glass Lining has a strong focus and expertise in glass-lined equipment, which is crucial for handling corrosive and sensitive materials in the pharmaceutical and chemical sectors.
• Comprehensive Solutions: The company offers comprehensive solutions, including design, manufacturing, and installation of glass-lined equipment, providing a one-stop shop for clients.
• In-house Manufacturing Capabilities: Having in-house manufacturing capabilities ensures quality control and allows for greater flexibility in meeting client specifications.
• Long-standing Client Relationships: The company has established long-term relationships with a diverse client base in the pharmaceutical and chemical industries.

Weaknesses:

• Dependence on Specific Industries: The company’s revenue is heavily reliant on the pharmaceutical and chemical sectors. A downturn in either of these sectors could significantly impact Standard Glass Lining’s performance.
• Competition from Established Players: The market for glass-lined equipment is competitive, with established domestic and international players like GMM Pfaudler and HLE Glascoat.
• Potential for Project-Based Revenue Fluctuations: The nature of manufacturing specialized equipment can lead to fluctuations in revenue depending on the size and timing of projects.

Opportunities:

• Growth in Pharmaceutical and Chemical Industries: The pharmaceutical and chemical industries in India and globally are expected to grow, driving demand for specialized equipment like glass-lined reactors and storage tanks.
• Increasing Regulatory Requirements: Stringent regulatory requirements in these industries, particularly concerning product quality and safety, can further drive demand for high-quality glass-lined equipment.
• Export Opportunities: The company can expand its export business to tap into growing demand in international markets.
• Technological Advancements in Glass Lining Technology: Continuous advancements in glass lining technology provide opportunities for the company to innovate and offer more efficient and durable equipment.

Threats:

• Economic Downturn: A global or domestic economic downturn could lead to reduced capital expenditure in the pharmaceutical and chemical industries, impacting demand for equipment.
• Fluctuations in Raw Material Prices: The cost of raw materials used in manufacturing glass-lined equipment, such as steel and glass, can fluctuate, impacting profitability.
• Competition Based on Price: Competition based primarily on price could put pressure on margins and profitability.
• Changes in Environmental Regulations: Increasingly stringent environmental regulations related to manufacturing processes and waste disposal could increase compliance costs.

Standard Glass Lining IPO GMP Details

What is IPO GMP?

The grey market premium (GMP) reflects the unofficial trading price of an IPO before its listing, offering insights into its potential market performance. A positive GMP indicates that the IPO may yield profits, while a negative GMP suggests a possible discount upon listing. However, it’s essential to recognize that IPO GMP can be highly volatile. Therefore, investors should not make decisions solely based on the GMP but should thoroughly assess all relevant factors before investing.

Standard Glass Lining IPO Subscription Status 

Total Application : 35,19,478

Note:

• *: “Shares Offered” and “Total Amount” are calculated based on the upper price of the issue price range.

• **: The portion of anchor investors (or market makers) is not included in the total number of shares offered.

Standard Glass Lining IPO  Allotment status 

Standard Glass Lining IPO allotment is expected on Thursday, January 9, 2025.

Standard Glass Lining IPO allotment status is not available at this time. Standard Glass Lining IPO – The allotment status will be available once the basis of allotment is finalized. Please revisit us to check the latest updates for Standard Glass Lining Technology Limited IPO allotment status.

To check Standard Glass Lining IPO allotment status, follow the steps below:

1. Click on the below allotment status check button.
2. Select Company Name.
3. Enter your PAN Number, Application Number or DP Client ID (Anyone).
4. Click on Search.

On securing the allotment, you will receive the credit of equivalent shares in your Demat account.

If you have any concerns or queries about the allotment status, contact Kfin Technologies Limited either by phone or email. Investors can call on 04067162222, 04079611000 or send an email with all relevant details to reachus@kfintech.com.

Standard Glass Lining IPO Contact Details

Standard Glass Lining Technology Limited
10th Floor, PNR High Nest,
Hydernagar, KPHB Colony
Hyderabad- 500085
Phone: + 040 3518 2204
Email: corporate@standardglr.com
Website: https://www.standardglr.com/

Disclaimer: Investing in Initial Public Offerings (IPOs) involves substantial risk, and financial returns are not guaranteed. The information provided should not be construed as financial or investment advice. Prospective investors are advised to consider their financial situation, investment objectives, and risk tolerance before participating in an IPO. It is recommended to consult with a qualified financial advisor or professional before making any investment decisions. Past performance is not indicative of future results. Investments in IPOs may be subject to market risk, including the potential loss of principal.

Want to Raise money for your company through SME IPO? Read More